Results 171 to 180 of about 130,849 (328)
Allosteric regulation of kinase activity in living cells. [PDF]
Godbole SS, Dokholyan NV.
europepmc +1 more source
Transient Allosteric Regulation of Catalysis by Effector Switching in a Pt2L4 Cage [PDF]
Joost N. H. Reek, Zoe Ashbridge
openalex +1 more source
[Eu(pda)2]− (pda = 1,10‐phenanthroline‐2, 9‐dicarboxylic acid) containing Δ/Λ‐[Co(en)3]3+ (en = ethylenediamine) exhibits CPL signals (|glum| ≈0.2 at maximum) at the f–f transition in [Eu(pda)2]−. The time‐resolved CPL reveals that the short‐lived components exhibit CPL.
Juri Yamashita +4 more
wiley +1 more source
Direct air capture (DAC) of carbon dioxide (CO2) emerges as a key strategy for climate crisis mitigation. Redox‐mediated electrochemical carbon capture offers a promising route for energy‐efficient DAC. This perspective discusses recent advances in the field, highlighting key challenges, such as oxygen interference at low CO2 concentrations, and ...
Tilmann J. Neubert, Martin Oschatz
wiley +1 more source
Structural basis for the allosteric regulation and dynamic assembly of DNMT3B. [PDF]
Lu J +5 more
europepmc +1 more source
Endoplasmic reticulum (ER) Ca2+ dysregulation drives β‐cell dysfunction under diabetic stressors like methylglyoxal, which inhibits the sarco/endoplasmic reticulum Ca2+‐ATPase (SERCA) pump through oxidative modifications. We show that synthetic SERCA activators restore pump activity after methylglyoxal‐induced damage.
Carlos Cruz‐Cortés +4 more
wiley +1 more source
Abstract BNC210 is an investigational small molecule selective negative allosteric modulator of the alpha‐7 nicotinic acetylcholine receptor (α7 nAChR). It is an anxiolytic compound with a novel mechanism of action. In a series of Phase 1 clinical trials in healthy volunteers, psychometric test batteries showed that BNC210 did not cause attention ...
Paul Rolan +7 more
wiley +1 more source
Biophysical Mechanism of Allosteric Regulation of Actin Capping Protein. [PDF]
Mooren OL +8 more
europepmc +1 more source
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch +9 more
wiley +1 more source
Allosteric Regulation of Bk Channel Gating by Ca2+ and Mg2+ through a Nonselective, Low Affinity Divalent Cation Site [PDF]
X. Zhang +2 more
openalex +1 more source

